Tilray Inc TLRY is trading higher Wednesday morning amid increased retail interest following the launch of a new medical cannabis brand.
What Happened: Tilray on Tuesday announced Symbios, a new medical cannabis brand it launched in order to provide a broader spectrum of formats and unique cannabinoid ratios at a better price point.
Symbios offers medical patients health and wellness products including flower, oils and pre-rolls.
“As we look ahead, we remain focused on building momentum across our three medical brands – Symbios, Aphria, and Tilray -- while meeting the large and growing demand for new, high-quality cannabis products that promote health, wellness, and wellbeing," said Irwin D. Simon, CEO of Tilray.
See Also: Is Tilray The Next Short Squeeze Candidate?
Retail Interest: Tilray is the top mentioned cannabis stock on the Subreddit r/wallstreetbets over the last 24 hours. The stock is also in the top ten most-mentioned stocks of all tickers on the popular Subreddit.
Price Action: Tilray has traded as high as $67 and as low as $4.41 over a 52-week period.
At last check Wednesday, the stock was up 8.85% at $22.01.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
